Currently holds positions in Harvard Bioscience Inc and Harvard Bioscience Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Harvard Bioscience Inc | June 5, 2017 - |
Chairman of the Board, President, Chief Executive Officer | Harvard Bioscience Inc | July 8, 2019 - |
Director | Harvard Bioscience Inc | April 30, 2015 - June 5, 2017 |
President, Chief Executive Officer, Director | Analogic Corp | June 5, 2007 - Oct. 31, 2016 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-21 | 2023-08-17 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
25,000
+0.9%
4.38109,500 USD |
25,000 +0.9% | 4.38 | 109,500 USD | |
2023-03-15 | 2023-03-15 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
20,000
+0.7%
2.6052,000 USD |
20,000 +0.7% | 2.60 | 52,000 USD | |
2022-12-02 | 2022-12-01 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
15,000
+0.7%
2.6139,150 USD |
15,000 +0.7% | 2.61 | 39,150 USD | |
2022-12-02 | 2022-11-30 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
15,000
+0.7%
2.4136,150 USD |
15,000 +0.7% | 2.41 | 36,150 USD | |
2022-08-18 | 2022-08-17 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
40,000
+1.8%
3.19127,600 USD |
40,000 +1.8% | 3.19 | 127,600 USD | |
2022-05-10 | 2022-05-09 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
10,000
+0.4%
3.4034,000 USD |
10,000 +0.4% | 3.40 | 34,000 USD | |
2022-05-10 | 2022-05-06 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
30,000
+1.3%
3.78113,400 USD |
30,000 +1.3% | 3.78 | 113,400 USD | |
2021-05-25 | 2021-05-21 |
Harvard Bioscience Inc
(HBIO)
|
S Sale |
24,312
-1.1%
7.14173,588 USD |
24,312 -1.1% | 7.14 | 173,588 USD | |
2021-05-21 | 2021-05-20 |
Harvard Bioscience Inc
(HBIO)
|
S Sale |
14,876
-0.6%
7.03104,578 USD |
14,876 -0.6% | 7.03 | 104,578 USD | |
2021-05-21 | 2021-05-19 |
Harvard Bioscience Inc
(HBIO)
|
S Sale |
39,188
-1.7%
7.17280,978 USD |
39,188 -1.7% | 7.17 | 280,978 USD | |
2021-03-16 | 2021-03-12 |
Harvard Bioscience Inc
(HBIO)
|
S Sale |
35,000
-1.5%
5.98209,300 USD |
35,000 -1.5% | 5.98 | 209,300 USD | |
2020-05-08 | 2020-05-07 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
10,000
+0.7%
2.5325,300 USD |
10,000 +0.7% | 2.53 | 25,300 USD | |
2019-11-13 | 2019-11-11 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
10,000
+0.7%
2.6126,100 USD |
10,000 +0.7% | 2.61 | 26,100 USD | |
2019-08-19 | 2019-08-16 |
Harvard Bioscience Inc
(HBIO)
|
B Purchase |
10,000
+0.7%
2.4924,850 USD |
10,000 +0.7% | 2.49 | 24,850 USD | |
2016-10-25 | 2016-10-24 |
Analogic Corp
(ALOG)
|
PS Planned sale |
500
-2.8%
83.5441,770 USD |
500 -2.8% | 83.54 | 41,770 USD | |
2016-07-25 | 2016-07-22 |
Analogic Corp
(ALOG)
|
PS Planned sale |
500
-2.6%
82.8241,410 USD |
500 -2.6% | 82.82 | 41,410 USD | |
2016-06-24 | 2016-06-22 |
Analogic Corp
(ALOG)
|
PS Planned sale |
500
-2.5%
82.3841,189 USD |
500 -2.5% | 82.38 | 41,189 USD | |
2016-03-23 | 2016-03-22 |
Analogic Corp
(ALOG)
|
PS Planned sale |
500
-2.3%
77.6338,817 USD |
500 -2.3% | 77.63 | 38,817 USD | |
2016-02-23 | 2016-02-22 |
Analogic Corp
(ALOG)
|
PS Planned sale |
500
-2.3%
73.6236,812 USD |
500 -2.3% | 73.62 | 36,812 USD | |
2016-01-25 | 2016-01-22 |
Analogic Corp
(ALOG)
|
PS Planned sale |
500
-2.2%
73.4736,734 USD |
500 -2.2% | 73.47 | 36,734 USD |